Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
investigational since 1995 Original developer / Merck Research Laboratories Mechanism / GHS-R1a agonist mimicking acyl-ghrelin binding Key pharmacokinetic advantage / oral bioavailability with 24-hour GH pulsatility IGF-1 elevation / sustained 40-60% increase at 25 mg daily over 12 months Primary safety signal / insulin resistance, edema, appetite stimulation Active clinical space / sarcopenia, frailty, GH deficiency alternatives Pipeline competitors / anamorelin (approved in Japan), macimorelin (FDA-approved diagnostic) Reformulation interest / transdermal, sustained-release, and receptor-biased analogs How MK-677 Works: The Mechanism Behind Pipeline Interest MK-677 activates the growth hormone secretagogue receptor (GHS-R1a), the same receptor bound by endogenous ghrelin
Based on your detailed feedback, we may suggest: Splitting the full dose into two smaller injections spaced apart
& Briggs, M
Pairs perfectly with creatine, beta-alanine, or other amino acids
US$ 29.31
US$ 20.12
US$ 23.37
US$ 28.76
US$ 20.30
US$ 24.66
US$ 22.14
US$ 28.77
US$ 25.65
US$ 22.55
